Trafalgar International (GCAN) Non-Current Assets (2018 - 2024)
Greater Cannabis Company (GCAN) posted quarterly Non-Current Assets of $417.0 for Q4 2024, down 92.3% year-over-year from $5417.0 in Q1 2024, and down 74.99% quarter-over-quarter from $1667.0 in Q3 2024.
Trafalgar International (GCAN) Non-Current Assets (2018 - 2024) Analysis & Trends
Greater Cannabis Company's Non-Current Assets history runs 7 years deep, the most recent figure standing at $417.0 for Q4 2024.
- In Q4 2024, Non-Current Assets fell 92.3% year-over-year to $417.0; the TTM figure through Sep 2025 stood at $417.0 (down 97.06% YoY), while the FY2024 annual figure was $417.0, down 92.3% from the prior year.
- Non-Current Assets for Q4 2024 stood at $417.0, down from $1667.0 in the prior quarter.
- The five-year high for Non-Current Assets was $24167.0 in Q1 2020, with the low at $417.0 in Q4 2024.
- The 5-year median for Non-Current Assets is $12292.0 (2022), against an average of $12292.0.
- The sharpest annual moves came in 2021 and 2024: Non-Current Assets dropped 20.69% in 2021, then plunged 92.3% in 2024.
- Greater Cannabis Company's Non-Current Assets stood at $20417.0 in 2020, then retreated by 24.49% to $15417.0 in 2021, then sank by 32.43% to $10417.0 in 2022, then slumped by 48.0% to $5417.0 in 2023, then slumped by 92.3% to $417.0 in 2024.
- Business Quant data shows GCAN's Non-Current Assets at $417.0 in Q4 2024, $1667.0 in Q3 2024, and $2917.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 2.96 Bn |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 417.00 |
| Sep 30, 2024 | 1,667.00 |
| Jun 30, 2024 | 2,917.00 |
| Mar 31, 2024 | 4,167.00 |
| Dec 31, 2023 | 5,417.00 |
| Sep 30, 2023 | 6,667.00 |
| Jun 30, 2023 | 7,917.00 |
| Mar 31, 2023 | 9,167.00 |
| Dec 31, 2022 | 10,417.00 |
| Sep 30, 2022 | 11,667.00 |
| Jun 30, 2022 | 12,917.00 |
| Mar 31, 2022 | 14,167.00 |
| Dec 31, 2021 | 15,417.00 |
| Sep 30, 2021 | 16,667.00 |
| Jun 30, 2021 | 17,917.00 |
| Mar 31, 2021 | 19,167.00 |
| Dec 31, 2020 | 20,417.00 |
| Sep 30, 2020 | 21,667.00 |
| Jun 30, 2020 | 22,917.00 |
| Mar 31, 2020 | 24,167.00 |